129 related articles for article (PubMed ID: 10467439)
1. [Improved tumor diagnosis using MRI with organ-specific contrast media. Wiesbaden, 12 May 1999].
Rofo; 1999 Jul; 171(1 Suppl):1-4. PubMed ID: 10467439
[No Abstract] [Full Text] [Related]
2. Real enhancement or merely increased contrast?
Chen JH
AJR Am J Roentgenol; 1997 Jan; 168(1):279-80. PubMed ID: 8976963
[No Abstract] [Full Text] [Related]
3. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Petersein J; Saini S; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
[TBL] [Abstract][Full Text] [Related]
4. [Overview of MRI contrast media. The case of endorem].
Duroux M
Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
[No Abstract] [Full Text] [Related]
5. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects.
Clément O; Siauve N; Cuénod CA; Frija G
Top Magn Reson Imaging; 1998 Jun; 9(3):167-82. PubMed ID: 9621405
[TBL] [Abstract][Full Text] [Related]
6. [Organ specific MRI contrast media in general practice].
Schima W
Wien Med Wochenschr Suppl; 2002; (113):8-11. PubMed ID: 12621828
[TBL] [Abstract][Full Text] [Related]
7. Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging.
Saokar A; Braschi M; Harisinghani M
Abdom Imaging; 2006; 31(6):660-7. PubMed ID: 16680506
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of Resovist-enhanced MRI: results of an Italian multicenter trial.
Lencioni R; Bartolozzi C;
Eur Radiol; 2004 Jan; 14 Suppl 1():C10. PubMed ID: 15113061
[No Abstract] [Full Text] [Related]
9. SPIO-MRI in the detection of hepatocellular carcinoma.
Araki T
J Gastroenterol; 2000; 35(11):874-6. PubMed ID: 11085500
[No Abstract] [Full Text] [Related]
10. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
Barentsz JO; Fütterer JJ; Takahashi S
Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
12. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future.
Soyer P
Radiology; 1996 Sep; 200(3):610-1. PubMed ID: 8756902
[No Abstract] [Full Text] [Related]
13. Advantages and differences of Resovist towards Gadolinium contrast in MRI with focus on metastatic liver lesions.
Reimer P; Balzer T
Eur Radiol; 2004 Jan; 14 Suppl 1():C4. PubMed ID: 15113058
[No Abstract] [Full Text] [Related]
14. European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients.
Chachuat A; Bonnemain B
Radiologe; 1995 Nov; 35(11 Suppl 2):S274-6. PubMed ID: 8588035
[No Abstract] [Full Text] [Related]
15. Experience with Resovist in gastroenterologic radiology and intervention.
Vogl TJ; Schwarz W; Marquart F; Parmentier S; Götz B; Thalhammer A; Hammerstingl R
Eur Radiol; 2004 Jan; 14 Suppl 1():C7-9. PubMed ID: 15113060
[No Abstract] [Full Text] [Related]
16. Area of paradoxical signal drop after the administration of superparamagnetic iron oxide on the T2-weighted image of a patient with lymphangitic metastasis of the liver.
Lee Y; Lee JS; Kim CM; Jeong JY; Choi JI; Kim MJ
Magn Reson Imaging; 2008 May; 26(4):577-82. PubMed ID: 18093780
[TBL] [Abstract][Full Text] [Related]
17. Re: Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
Kroon BK; Horenblas S
J Urol; 2006 Mar; 175(3 Pt 1):1174. PubMed ID: 16469648
[No Abstract] [Full Text] [Related]
18. [The characterization value of feridex-enhanced MR imaging for focal hepatic lesions in reference to their histological pathology].
Yang HF; Zhou XP; Yu JQ; Song B; Guang YS; Zhang HY; Chen X
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):548-50. PubMed ID: 16042902
[No Abstract] [Full Text] [Related]
19. State of the art in diagnostic liver imaging.
Lamprecht A; Wagner B
Eur Radiol; 2004 Jan; 14 Suppl 1():C2-3. PubMed ID: 15113057
[No Abstract] [Full Text] [Related]
20. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
Pleger B; Beyer HK; Laufer U
Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
[No Abstract] [Full Text] [Related]
[Next] [New Search]
